1 mg Arsenic Trioxide Injection is a medication used to treat a type of cancer called acute promyelocytic leukemia (APL). APL is a subtype of acute myeloid leukemia (AML), and it is characterized by the abnormal accumulation of immature white blood cells known as promyelocytes. Arsenic trioxide has shown remarkable efficacy in inducing remission in patients with APL, particularly those who have not responded well to standard chemotherapy or have relapsed after initial treatment. 1 mg Arsenic Trioxide Injection works through multiple mechanisms, including inducing apoptosis (cell death) in cancer cells, promoting the maturation of abnormal cells into more normal blood cells, and inhibiting the growth of new blood vessels that support tumor growth.
Form - Liquid